Financhill
Back

Capricor Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing slight selling pressure.

Capricor Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 8.56 Buy
20-day SMA: 6.94 Buy
50-day SMA: 6.85 Buy
200-day SMA: 9.12 Buy
8-day EMA: 11.14 Buy
20-day EMA: 8.1 Buy
50-day EMA: 6.9 Buy
200-day EMA: 4.1 Buy

Capricor Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.8 Buy
Relative Strength Index (14 RSI): 92.92 Buy
Chaikin Money Flow: -5886076 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.07 - 11.57) Buy
Bollinger Bands (100): (4.45 - 9.37) Buy

Capricor Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Capricor Therapeutics, Inc. Stock

Is Capricor Therapeutics, Inc. Stock a Buy?

CAPR Technical Analysis vs Fundamental Analysis

Buy
61
Capricor Therapeutics, Inc. (CAPR) is a Buy

Is Capricor Therapeutics, Inc. a Buy or a Sell?

Capricor Therapeutics, Inc. Stock Info

Market Cap:
1.4B
Price in USD:
29.96
Share Volume:
57M

Capricor Therapeutics, Inc. 52-Week Range

52-Week High:
40.37
52-Week Low:
4.30
Buy
61
Capricor Therapeutics, Inc. (CAPR) is a Buy

Capricor Therapeutics, Inc. Share Price Forecast

Is Capricor Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Capricor Therapeutics, Inc.

Is Capricor Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $1.68 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.07 per share, and an increase next year of $2.50 per share.

Technical Analysis of Capricor Therapeutics, Inc.

Should I short Capricor Therapeutics, Inc. stock?

* Capricor Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.